EMG
ALGS icon

ETF Managers Group’s Aligos Therapeutics ALGS Stock Holding History

ETF Managers Group’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-540
Closed -$17K – 704
2022
Q2 		$17K Buy
540
+23
+4% +$781 ﹤0.01% 741
2022
Q1 		$27K Buy
517
+2
+0.4% +$160 ﹤0.01% 679
2021
Q4 		$154K Sell
515
-107
-17% -$39K ﹤0.01% 621
2021
Q3 		$236K Buy
622
+172
+38% +$68K ﹤0.01% 608
2021
Q2 		$238K Sell
450
-17
-4% -$10.8K ﹤0.01% 602
2021
Q1 		$244K Sell
467
-275
-37% -$183K ﹤0.01% 603
2020
Q4 		$482K Buy
+742
New +$361K 0.01% 362

Other funds holding ALGS

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return